Cresco Labs (CSE: CL) (OTCQX: CRLBF) - Investor Dashboard
|Market Focus:||United States|
|Employees:||>2700 as of July 2021|
Cresco Labs – Management Team
Charles Bachtell – CEO Charles Bachtell is the CEO of Cresco Labs, LLC. Bachtell is an attorney and brings with him deep legal expertise in both corporate governance and complex regulatory compliance. Bachtell lead the efforts for Cresco to the win seven licenses that it currently holds and continues to work to ensure that Cresco remains an industry leader. Bachtell is a founding member of the Illinois Cannabis Bar Association and the Medical Cannabis Alliance of Illinois. Prior to Cresco Labs, Bachtell served for eight years as the Executive Vice President and General Counsel of Guaranteed Rate. Bachtell has established himself as one of the industry’s foremost authorities on regulatory affairs and compliance in one of the nation’s most heavily regulated industries.
Executive Chairman of the Board
Tom Manning has been a member of the Cresco Labs board since 2016. He was elected the Chair of the Board in 2019 and assumed the role of Executive Chair in 2020. Manning’s past experience includes serving as CEO and Chairman of Dun & Bradstreet and as CEO of Cerberus Asia Operations & Advisory Limited. Manning has deep experience in capital markets, organizational development and corporate strategy.
Co-Founder and Director
Prior to forming Cresco Labs, Robert Sampson had more than 20 years of operating experience in large business, including 12 years in the heavily regulated mortgage industry, having served as Chief Operating Officer at Guaranteed Rate, the nation’s seventh largest retail mortgage bank. As the former COO of Cresco Labs, Sampson oversaw the construction of two 40,000 sqft cement precast structures and one 30,000 sqft hybrid greenhouse structure and was responsible for all facility operations and systems. Sampson is currently the CEO of Bemortgage based in Chicago.
Dennis Olis has extensive experience in financial planning, accounting, internal audit, operations and M&A. Before joining Cresco, Olis served as the CFO for Allscripts Healthcare Solutions. In this position, he was responsible for the company’s financial strategy, and he oversaw the $185 million acquisition of McKesson’s healthcare business.
In his role as CIO, Mo Dastagir is responsible for overseeing the company’s technological infrastructure and implementing technological systems. Prior to joining Cresco, Dastagir was the Vice President and Chief Technology Officer at Sears Holding Corporation. In this role, he was responsible for managing the technology programs of Sears Home Services Business. His past experience also includes leadership roles with Novartis Pharmaceuticals, Roche Pharmaceuticals, and Amazon Hyderabad.
Ty Gent is responsible for operational efficiency and helping to scale the business in his role as COO at Cresco Labs. Gent is a veteran of the CPG industry with more than 35 years of experience. Prior to joining Cresco, he was the Chief Supply Chain Officer at US Foods. He also worked in various leadership positions at PepsiCo for 30 years.
Chief Commercial Officer
Greg Butler is the company’s first Chief Commercial Officer. He has a background in brand growth, consumer packaged goods, and capital management. Butler has previously worked with companies including Molson Coors, Johnson & Johnson, Pfizer, and Walgreens. As Chief Commercial Officer, he will focus on Cresco Labs’ commercial strategic planning.
Chief People Officer
Angie Demchenko joined Cresco Labs as its first Chief People Officer. Previously, she served as the Vice President, Head of Human Resources at Starwood Retail Partners. In her current role, Demchenko is responsible for employee benefits, recruitment, compensation and performance management.
Chief Communications Officer
Jason Erkes is the company’s first Chief Communications Officer. He served Cresco as a consultant for a number of years before officially joining the team. Erkes is a former Emmy-winning journalist and entrepreneur.
Significant Insider Ownership
Charles Bachtell, CEO:
15.7 million shares
Joe Caltabiano, Former President:
17.6 million shares
Dominic Sergi, Director:
11.3 million shares
Robert Sampson, Director:
13.1 million shares
Randy Podolsky, Director:
1.0 million shares
Gerald Corcoran, Director:
1.0 million shares
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Cresco Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.